Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:38 PM
Ignite Modification Date:
2025-12-24 @ 7:38 PM
NCT ID:
NCT05712603
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years;
* Suspected by treating physician to suffer from a severe stage of NAFLD-fibrosis.
Exclusion Criteria:
* Previous diagnosis of advanced (≥F3) liver fibrosis;
* Any other known chronic liver disease (alcoholic steatohepatitis, hepatitis B, hepatitis C, autoimmune hepatitis, hemochromatosis, Wilsons disease, alpha-1-antitrypsin deficiency);
* Drugs that may cause drug-induced hepatic steatosis, (table provided elsewhere)
* Present excessive alcohol use, defined as \> 2 units/day for women and \> 3 units/day for men;
* A psychiatric, addictive or any other disorder that compromises the subject's ability to understand the study content and to give written informed consent for the participation in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05712603
Study Brief:
Protocol Section:
NCT05712603